Arg and DAP3 expression was correlated with human thymoma stage

Clinical and Experimental Metastasis

Volumn 21, Issue 6, 2004, Pages 507-513

  Sasaki, Hidefumi ^a,b,c   Ide, Nobuyuki ^b   Yukiue, Haruhiro ^a   Kobayashi, Yoshihiro ^a   Fukai, Ichiro ^a   Yamakawa, Yosuke ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

Author keywords

Arg; Chromosome 1q; DAP3; Microarray; Progression; Thymoma

Indexed keywords

ARGININE TYROSINE KINASE; DEATH ASSOCIATED PROTEIN 3; MESSENGER RNA; PROTEIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; CANCER TISSUE; CHROMOSOME 1Q; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IONIZING RADIATION; MALE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; THYMOMA; WORLD HEALTH ORGANIZATION;

APOPTOSIS REGULATORY PROTEINS; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-TYROSINE KINASES; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; THYMOMA; THYMUS NEOPLASMS;

EID: 12544252846     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-004-2153-3     Document Type: Article

References (31)

1. Lardinois D, Rechsteiner R, Lang RH et al. Prognostic relevance of Masaoka and Muller-Hermelink classification in patients with thymic tumors. Ann Thorac Surg 2000; 69: 1550-5.
2. Rios A, Torres J, Galindo PJ et al. Prognostic factors in thymic epithelial neoplasms. Eur J Cardiothorac Surg 2002; 21: 307-13.
3. Sperling B, Marschall J, Kennedy R et al. Thymoma: A review of the clinical and pathological findings in 65 cases. Can J Surg 2003; 46: 37-42.
4. Iyer VR, Eisen MB, Ross DT et al. The transcriptional program in the response of human fibroblasts to serum. Science (Washington, DC) 1999; 283: 83-7.
5. Lockhart DJ, Dong H, Byrne M et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996; 14: 1675-80.
6. DeRisi J, Penland L, Brown PO et al. Use a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996; 14: 457-60.
7. Pietu G, Alibert O, Guichard V et al. Novel gene transcripts preferentially expressed in human muscles revealed by quantitative hybridization of a high density cDNA array. Genome Res 1996; 6: 492-503.
8. Sasaki H, Ide N, Fukai I et al. Gene expression analysis of human thymoma correlates with tumor stage. Int J Cancer 2002; 101: 342-7.
9. Sasaki H, Ide N, Sendo F et al. Glycosylphosphatidyl inositol-anchored protein (GPI-80) gene expression is correlated with human thymoma stage. Cancer Sci 2003; 94: 809-13.
10. Sasaki H, Fujii Y, Ide N. Chromosome 6 abnormalities correlate with thymoma progression. Am J Pathol 2003; 163: 2635-6.
11. Inoue M, Marx A, Zettl A et al. Chromosome 6 suffer frequent and multiple aberrations in thymoma. Am J Pathol 2002; 161: 1507-13.
12. Wittwer CT, Ririe KM, Andrew RV et al. The LightCycler: A microvolume multisample fluorimeter with rapid temperature control. Biotechniques 1997; 22: 176-81.
13. Masaoka A, Monden Y, Nakahara K et al. Follow up study of thymomas with special reference to their clinical stages. Cancer 1981; 48: 2485-92.
14. Kruh GD, Perego R, Miki T et al. The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proc Natl Acad Sci USA 1990; 87(15): 5802-6.
15. Mysliwiec T, Perego R, Kruh GD. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain. Oncogene 1996; 12(3): 631-40.
16. Okuda K, Weisberg E, Gilliland DG et al. ARG tyrosine kinase activity is inhibited by STI571. Blood 2001; 97(8): 2440-8.
17. Lu TJ, Lu TL, Su IJ et al. Tyrosine kinase expression profile in bladder cancer. Anticancer Res 1997; 17(4A): 2635-7.
18. Meric F, Lee WP, Sahin A et al. Expression profile of tyrosine kinase in breast cancer. Clin Cancer Res 2002; 8(2): 361-7.
19. Chen W-S, Kung H-J, Yang W-K et al. Comparative tyrosine kinase profiles in colorectal cancers: enhanced arg expression in carcinoma as compared with adenoma and normal mucosa. Int J Cancer 1999; 83: 579-84.
20. Wu CW, LI AF, Chi CW et al. Arg tyrosine kinase expression in human gastric adenocarcinoma in associated with vessel invasion. Anticancer Res 2003; 23: 205-10.
21. Sasaki H, Yukiue H, Kobayashi Y et al. Elevated serum vascular endothelial growth factor an basic fibroblast growth factor levels in patient with thymic epithelial neoplasms. Surg Today 2003; 31: 1038-40.
22. Okuda K, Weisberg E, Gilliland DG et al. ARG tyrosine activity is inhibited by STI571. Blood 2001; 97: 2240-8.
23. Mariani L, Beaudry C, McDonough WS et al. Death-associated protein 3 (DAP-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro. Clin Cancer Res 2001; 7: 2480-9.
24. Kissil JL, Deiss LP, Bayewitch M et al. Isolation of DAP3, a novel mediator of interferon-gamma-induced cell death. J Bio Chem 1995; 270: 27932-6.
25. Cavdar Koc E, Ranasinghe A, Burkhart W et al. A new face on apoptosis: death-associated protein 3 and PDCD9 are mitochondrial ribosomal proteins. FEBS Lett 2001; 492 (1-2): 166-70.
26. Kissil JL, Cohen O, Raveh T et al. Structure function analysis of an evolutionary conserved protein, DAP-3, which mediates TNF-α and Fas-induced cell death. EMBO J 1999; 18: 353-62.
27. Aisemberg AC, Wilkes B, Harris NL et al. The predomonant lymphocyte in most thymomas and in nonneoplastic thymus from patients with myasthenia gravis is the cortical thymocytes. Clin Immunol Immunopathol 1985; 35: 130-6.
28. Eimoto T, Tesgima K, Shirakusa T et al. Heterogeneity of epithelial cells and reactive components in thymomas: An ultrastructural and immunohistochemical study. Ultrastruct Pathol 1986; 10: 157-73.
29. Yokoyama T, Tanahashi M, Tateyama H et al. Flow-cytometric diagnosis of thymoma using needle biopsy specimens. Surg Today 2003; 33: 163-8.
30. Li S, Juco J, Mann KP et al. The Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. Am J Clin Pathol 2004; 121: 268-74.
31. Okumura M, Miyoshi S, Fujii Y et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms. Am J Surg Pathol 2001; 25: 103-10.